ImmunoPrecise Antibodies Ltd. ( IPA) - Key Metrics
Stock symbol IPA is outdated, potentially delisted? Maybe it is available on other exchange?
IPA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0.19 | -$0.66 | -$0.04 | -$0.04 |
| 2025Q2 | $0.22 | -$0.09 | -$0.08 | -$0.08 |
| 2025Q1 | $0.19 | -$0.15 | -$0.07 | -$0.08 |
| 2024Q4 | $0.24 | -$0.67 | -$0.10 | -$0.14 |
IPA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -0.26 |
| 2025Q2 | ? | -1.83 |
| 2025Q1 | ? | -1.85 |
| 2024Q4 | ? | -0.66 |
IPA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | ? | ? |
| 2025Q3 | -5.92% | ? |
| 2025Q2 | -12.34% | ? |
| 2025Q1 | -7.06% | ? |
| 2024Q4 | -7.93% | ? |
IPA
Price: $1.55
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.66 USD
P/E Ratio: -3.14
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 28913
Market Capitalization: 95.5 million